Clinical Trials

Keywords/SWOG Study Number

Area of Research

Accrual Status

Any

Open

Closed

Limit to SWOG Trials

All Trials

SWOG Trials Only

Show only published studies

Study Type

Treatment

Study Chair

Participating Institution

Phase

Cancer Control Subcommittee

Study Sponsor

FDA Registration Trial

Uses PRO Forms

1033 Results

View

Closed

Phase

Accrual

63%

Published

SWOG Clinical Trial Number

SWOG-8904

Phase II Trials of Merbarone and Piroxantrone in Ovarian Cancer

Activated

12-01-1990

Closed

02-15-1993

Closed

Phase

Accrual

14%

SWOG Clinical Trial Number

SWOG-8935

Evaluation of Continuous Infusion Interleukin-2 (IL-2) in Patients with Squamous Cell Carcinoma of the Head and Neck, Phase II

Activated

11-15-1990

Closed

06-15-1992

Closed

Phase

Accrual

46%

Published

SWOG Clinical Trial Number

SWOG-8730

Evaluation of Amonafide in Esophageal Cancer

Activated

11-01-1990

Closed

04-15-1992

Closed

Phase

Accrual

77%

Published

SWOG Clinical Trial Number

SWOG-8936

Evaluation of Piroxantrone in Gastric Carcinoma

Activated

11-01-1990

Closed

06-15-1992

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-9038

Extended Administration of Oral Etoposide and Cyclophosphamide for the Treatment of Advanced Non-Small Cell Lung Cancer

Activated

11-01-1990

Closed

07-01-1991

Closed

Phase

Accrual

77%

Published

SWOG Clinical Trial Number

SWOG-9006

A Phase II 19F Magnetic Resonance Spectroscopy (MRS) Study of 5-FU and Correlation with Clinical Results of 5-FU/Leucovorin (LV) Therapy in Patients with Carcinomas of the Gastrointestinal Tract

Research Committee(s)

Gastrointestinal Cancer

Activated

10-15-1990

Closed

11-01-1996

Closed

Phase

Accrual

63%

Published

SWOG Clinical Trial Number

SWOG-8956

Study of Cisplatin and 5-FU Infusion for Treatment of Advanced and/or Recurrent Metastatic Carcinoma of the Urinary Bladder

Research Committee(s)

Genitourinary Cancer

Activated

10-01-1990

Closed

06-15-1993

Closed

Phase

Accrual

39%

Published

SWOG Clinical Trial Number

SWOG-9028

A Phase III Randomized Trial of Combination Therapy for Multiple Myeloma Comparison of (1) VAD to VAD/ Quinine for Induction with Crossover to VAD/ Quinine for VAD Induction Failures; (2) Alpha-2b Interferon or Alpha-2b Interferon plus Prednisone for Remission Maintenance

Research Committee(s)

Myeloma

Activated

10-01-1990

Closed

05-15-1994

Closed

Phase

Published

SWOG Clinical Trial Number

SWOG-8855

Prognostic Value of Cytometry Measurements of Cellular DNA Parameters in Head and Neck Cancer Patients, Ancillary

Research Committee(s)

Head and Neck Cancer

Activated

09-15-1990

Closed

09-01-2002

Closed

Phase

Accrual

28%

Published

SWOG Clinical Trial Number

SWOG-8922

Phase I Trial of Doxorubicin, DTIC and Ifosfamide with Recombinant Granulocyte-Macrophage Colony Stimulating Factor in Advanced Soft Tissue Sarcomas

Research Committee(s)

Sarcoma

Activated

09-15-1990

Closed

09-15-1992

Closed

Phase

Accrual

40%

SWOG Clinical Trial Number

SWOG-8914

Standard Dose Carboplatin/Cyclophosphamide/GM-CSF vs. Intensive Carboplatin/Cyclophosphamide/GM-CSF Induction Therapy - Second-Look Cytoreductive Surgery - Followed by High Dose Day 1 and Day 8 IV Cisplatin for Patients with Stages III and IV Suboptimal Disease Ovarian Cancer

Activated

09-15-1990

Closed

06-15-1994

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-8933

Evaluation of Piroxantrone in Pancreatic Adenocarcinoma

Activated

09-01-1990

Closed

09-15-1991

Closed

Phase

Accrual

76%

Published

SWOG Clinical Trial Number

SWOG-8945

Evaluation of Piroxantrone in Patients with Advanced Renal Cell Carcinoma

Activated

09-01-1990

Closed

05-01-1991

Closed

Phase

Accrual

SWOG Clinical Trial Number

SWOG-8901

Clinical Trial of the Most Active Drugs Selected by Clonogenic Assay to be Administered by the Intrahepatic Arterial Route for Colorectal Cancer Metastatic to the Liver

Activated

09-01-1990

Closed

10-15-1991

Closed

Phase

Accrual

100%

SWOG Clinical Trial Number

SWOG-9037 (CALGB-9196)

Prediction of Recurrence and Survival in Node-Negative Breast Cancer Patients Using a Panel of Prognostic Factors: A Companion Protocol to SWOG-8897 (EST-2188, CALGB-8897, INT-0102)

Research Committee(s)

Genitourinary Cancer

Activated

09-01-1990

Closed

05-15-1993

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-8797 (INT-0107) (GOG-109) (RTOG-91-12)

A Randomized Comparison of 5-FU Infusion and Bolus Cisplatin as an Adjunct to Radiation Therapy, Versus Radiation Therapy Alone in Selected Patients with Stages I-A2, I-B and II-A Carcinoma of the Cervix Following Radical Hysterectomy and Node Dissection

Research Committee(s)

Gynecologic Cancer

Activated

09-01-1990

Closed

12-15-1996

Closed

Phase

SWOG Clinical Trial Number

SWOG-8861

Evaluation of Quality of Life in Patients with Clinical Stage A2 or B Adenocarcinoma of the Prostate Enrolled on SWOG-8890 (Int-CR-87-017)

Activated

07-15-1990

Closed

01-01-1992

Closed

Phase

Accrual

72%

Published

SWOG Clinical Trial Number

SWOG-8911

Evaluation of Piroxantrone in Refractory Carcinoma of the Breast

Activated

07-01-1990

Closed

05-15-1993

Closed

Phase

Accrual

45%

Published

SWOG Clinical Trial Number

SWOG-8834

A Phase II Evaluation of Fazarabine in Central Nervous System Tumors

Research Committee(s)

Brain Cancer

Activated

07-01-1990

Closed

12-01-1991

Closed

Phase

Accrual

83%

Published

SWOG Clinical Trial Number

SWOG-8930

Phase II Trial of Piroxantrone for Advanced or Metastatic Soft-Tissue Sarcomas

Activated

06-15-1990

Closed

12-01-1991